Thyroid Disorders: It's Very Personal

Abstract

Get full access to this article

View all access options for this article.

References

Emerson

. 2010. May, 2010: A Personalized Medicine month in Minneapolis, Minnesota. Thyroid, 20:355–356.

Ross

CJD

, Visscher

, Sistonen

, Brunham

, Pussegoda

, Loo

, Rieder

, Koren

, Carleton

, Hayden

. CPNDS Consortium. 2010. The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology. Thyroid, 20:681–687.

Das

, Cagan

. 2010. Drosophila as a novel therapeutic discovery tool for thyroid cancer. Thyroid, 20:689–695.

Xing

. 2010. Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer. Thyroid, 20:697–706.

Richards

. 2010. Familial syndromes associated with thyroid cancer in the era of personalized medicine. Thyroid, 20:707–713.

Tomer

. 2010. The genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid, 20:715–725.

Davies

, Yin

, Latif

. 2010. The genetics of the thyroid-stimulating hormone receptor—history and relevance. Thyroid, 20:727–736.

Dittmar

, Kahaly

. 2010. Genetics of the autoimmune polyglandular syndrome type 3 variant. Thyroid, 20:737–743.

Spritz

. 2010. Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease. Thyroid, 20:745–754.

10.

Brent

. 2010. Environmental exposures and autoimmune thyroid disease. Thyroid, 20:755–761.

11.

Barbesino

. 2010. Drugs affecting thyroid function. Thyroid, 20:763–770.

12.

Tufano

, Kandil

. 2010. Considerations for personalized surgery in patients with papillary thyroid cancer. Thyroid, 20:771–776.

13.

Stan

, Bahn

. 2010. Risk factors for development or deterioration of Graves' ophthalmopathy. Thyroid, 20:777–783.

14.

Ponto

, Zang

, Kahaly

. 2010. The tale of radioiodine and Graves' orbitopathy. Thyroid, 20:785–793.